Overview

This trial is active, not recruiting.

Condition breast cancer
Treatment mri, digital mammography, ultrasound and positron emission tomography (pet)
Sponsor University of Pennsylvania
Start date March 2002
End date July 2007
Trial size 400 participants
Trial identifier NCT00367666, NIH funded, Protocol 414500

Summary

This project is aimed at investigating the relative diagnostic and synergy of four state of the art breast imaging techniques (magnetic resonance imaging (MRI), full-field digital mammography (DMAM), ultrasound, and positron emission tomography (PET)) with respect to determining the extent of breast cancer.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation non-randomized
Intervention model single group assignment
Masking open label
Primary purpose diagnostic

Eligibility Criteria

Female participants from 18 years up to 80 years old.

Inclusion Criteria: - Women recently diagnosed with Breast Cancer - Will be undergoing surgery (after study) at the Hospital of the University of Pennsylvania Exclusion Criteria: - Contraindications to MRI - previously diagnosed with breast cancer (in the smae breast) within the past 5 years - Patients with known locally advanced cancer (prior to study entry) being treated with preoperative adjuvant therapy. - Pregnant women

Additional Information

Official title Evaluation of Multimodality Breast Imaging: Lesion Staging
Principal investigator Abass Alavi, MD
Trial information was received from ClinicalTrials.gov and was last updated in May 2007.
Information provided to ClinicalTrials.gov by University of Pennsylvania.